Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease
Authors:
- Joseph B MuhlesteinJMJoseph B Muhlestein
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarctionJACC, 1998
- C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial InfarctionCirculation, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Inflammation, Atherosclerosis, and Ischemic Events — Exploring the Hidden Side of the MoonNew England Journal of Medicine, 1997
- Production of C-reactive protein and risk of coronary events in stable and unstable anginaThe Lancet, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional studyBMJ, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White MenArchives of internal medicine (1960), 1992
- The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association.Circulation, 1990